IDEXX Laboratories (BSP:I1DX34) Ending Cash Position : R$1,979 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Ending Cash Position?

IDEXX Laboratories's Ending Cash Position for the quarter that ended in Mar. 2024 was R$1,979 Mil.

IDEXX Laboratories's quarterly Ending Cash Position increased from Sep. 2023 (R$1,638 Mil) to Dec. 2023 (R$2,224 Mil) but then declined from Dec. 2023 (R$2,224 Mil) to Mar. 2024 (R$1,979 Mil).

IDEXX Laboratories's annual Ending Cash Position declined from Dec. 2021 (R$817 Mil) to Dec. 2022 (R$590 Mil) but then increased from Dec. 2022 (R$590 Mil) to Dec. 2023 (R$2,224 Mil).

IDEXX Laboratories Ending Cash Position Historical Data

The historical data trend for IDEXX Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Ending Cash Position Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

370.74

1,975.19

816.87

590.35

2,224.18

IDEXX Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															580.07	644.76	1,638.15	2,224.18	1,979.14

IDEXX Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

IDEXX Laboratories's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	551.453	+	1672.723
	=	2,224

IDEXX Laboratories's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2260.491	+	-281.354
	=	1,979

IDEXX Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (BSP:I1DX34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines